Aviva preferred over L&G as broker reviews life insurers

UBS prefers Aviva over Legal & General, citing Aviva's well‑protected balance sheet, higher capital generation yield (UBS: 12% FY27E vs L&G 10%), lower payout ratio (~75% vs L&G 100%) and projected solvency build of ~7pp/year to 220% by FY30E (vs L&G drag of ~4pp/year to 205%). UBS keeps L&G at Neutral given high market sensitivities and flags potential solvency weakness under an extreme credit shock (Aviva stays above its 160–180% working range; L&G could fall to ~130%). UBS assigns 750p target to Aviva (current 626p) and 260p to L&G (current 259.6p); near‑term investor focus ahead of FY25 will be Aviva general insurance performance/management actions and L&G institutional retirement margins, buybacks and investment variances.

Analysis

Market structure: UBS’s call makes Aviva (LSE:AV.) the beneficiary of a flows and sentiment rotation within UK life insurers; higher operating capital generation (12% FY27E vs 10% for LGEN) and a lower payout (75% vs 100%) imply Aviva can sustain buybacks and dividends without eroding solvency, concentrating demand for AV equity and tightening its equity risk premium. L&G (LSE:LGEN) and M&G face the opposite pressure—higher market sensitivity and potential solvency drag (L&G -4pp/yr to 205% by FY30E) will constrain capital returns and may force more conservative pricing in institutional retirement products, hurting NBM and margins.

Risk assessment: Immediate (days) risk is headline-driven volatility around the UBS note and any initial FY25 guidance leaks; short-term (weeks/months) focus is on FY25 results, buyback size and investment variances; long-term (years) tail risk is an extreme credit shock—UBS estimates L&G solvency could fall to ~130% versus Aviva staying above its 160–180% working range—this is a low-prob/high-impact outcome that would materially reprice subordinated debt and equity. Hidden dependencies include sensitivity to gilt curve moves, swap spreads and credit spreads (asset-liability mismatches), and reinsurance cost/availability which can amplify GI volatility.

Trade implications: Implement a relative-value pair: long AV vs short LGEN equal-notional to express higher capital generation and lower tail exposure (12–24 month horizon). Use defined-risk option overlay: buy 12-month AV call spreads (e.g., Jan-27 650/850p) to cap premium and buy protection (Jan-27 220p puts) if naked short LGEN. Consider selective long Phoenix (PHNX.L) exposure as UBS-favoured alternative to L&G/M&G, size 2–4% portfolio.

Contrarian angles: The market may be underestimating Aviva’s upside from active balance-sheet management—UBS target 750p implies ~20% upside from 626p today—while simultaneously pricing L&G as if it can’t meaningfully rebuild capital. That consensus misses counterfactuals: a benign gilt/credit backdrop or stronger GI underwriting could accelerate Aviva’s buybacks and rerating; conversely, an underwriting miss would rapidly unwind AV’s premium—hence prefer defined-risk structures over vanilla longs.

Key Decisions for Investors

• Establish a 3% net-long position in Aviva (LSE:AV.) over the next 4–8 weeks, targeting 750p within 12–18 months (UBS target) and place a tactical stop-loss at ~560p (≈10% below current 626p) to limit downside if GI/solvency signals deteriorate.
• Implement a pair trade: go long AV (3% portfolio) and short LGEN (3% portfolio) equal-notional to isolate relative capital-generation and solvency differences; horizon 12–24 months, rebalance after FY25 results and any buyback announcements.
• Use options to define risk: buy a Jan-2027 AV call spread 650p/850p to cap premium while keeping upside exposure; size so max premium = 0.5–1.0% portfolio. If short LGEN, hedge with Jan-2027 220p puts sized to 50–75% of short position.
• Rotate modestly into Phoenix Group (PHNX.L) with a 2% tactical allocation as UBS’s alternative pick, and reduce outright long exposure to M&G and other high market-sensitivity insurers by 2–4% pending FY25 results.
• Monitor three catalysts over next 30–90 days—(1) Aviva FY25 trading update and GI loss ratio, (2) L&G Institutional Retirement NBM and announced buyback quantum, (3) 10y UK gilt and swap spread moves (move >25bps in either direction)—and trim or scale positions if solvency projections shift by >5 percentage points.